Literature DB >> 33128066

Disseminated Effects in Agent-Based Models: A Potential Outcomes Framework and Application to Inform Preexposure Prophylaxis Coverage Levels for HIV Prevention.

Ashley L Buchanan, S Bessey, William C Goedel, Maximilian King, Eleanor J Murray, Samuel R Friedman, M Elizabeth Halloran, Brandon D L Marshall.   

Abstract

Preexposure prophylaxis (PrEP) for prevention of human immunodeficiency virus (HIV) infection may benefit not only the person who uses it but also their uninfected sexual risk contacts. We developed an agent-based model using a novel trial emulation approach to quantify disseminated effects of PrEP use among men who have sex with men in Atlanta, Georgia, from 2015 to 2017. Model components (subsets of agents connected through partnerships in a sexual network but not sharing partnerships with any other agents) were first randomized to an intervention coverage level or the control group; then, within intervention components, eligible agents were randomized to receive or not receive PrEP. We calculated direct and disseminated (indirect) effects using randomization-based estimators and report corresponding 95% simulation intervals across scenarios ranging from 10% coverage in the intervention components to 90% coverage. A population of 11,245 agents was simulated, with an average of 1,551 components identified. When comparing agents randomized to no PrEP in 70% coverage components with control agents, there was a 15% disseminated risk reduction in HIV incidence (risk ratio = 0.85, 95% simulation interval: 0.65, 1.05). Persons not on PrEP may receive a protective benefit by being in a sexual network with higher PrEP coverage. Agent-based models are useful for evaluating possible direct and disseminated effects of HIV prevention modalities in sexual networks.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; HIV prevention; agent-based models; interference/dissemination; men who have sex with men; preexposure prophylaxis

Year:  2021        PMID: 33128066      PMCID: PMC8096482          DOI: 10.1093/aje/kwaa239

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  41 in total

1.  Bounding the infectiousness effect in vaccine trials.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

2.  Toward Causal Inference With Interference.

Authors:  Michael G Hudgens; M Elizabeth Halloran
Journal:  J Am Stat Assoc       Date:  2008-06       Impact factor: 5.033

3.  Formalizing the role of agent-based modeling in causal inference and epidemiology.

Authors:  Brandon D L Marshall; Sandro Galea
Journal:  Am J Epidemiol       Date:  2014-12-05       Impact factor: 4.897

4.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

5.  Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Roger Chou; Christopher Evans; Adam Hoverman; Christina Sun; Tracy Dana; Christina Bougatsos; Sara Grusing; P Todd Korthuis
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

6.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

Review 7.  Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.

Authors:  Kerry A Thomson; Jared M Baeten; Nelly R Mugo; Linda-Gail Bekker; Connie L Celum; Renee Heffron
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

Review 8.  HIV prevention trial design in an era of effective pre-exposure prophylaxis.

Authors:  Amy Cutrell; Deborah Donnell; David T Dunn; David V Glidden; Anneke Grobler; Brett Hanscom; Britt S Stancil; R Daniel Meyer; Ronnie Wang; Robert L Cuffe
Journal:  HIV Clin Trials       Date:  2017-10-17

9.  Correction: Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study.

Authors:  Jason R Gantenberg; Maximilian King; Madeline C Montgomery; Omar Galárraga; Mattia Prosperi; Philip A Chan; Brandon D L Marshall
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

10.  Effect of Racial Inequities in Pre-exposure Prophylaxis Use on Racial Disparities in HIV Incidence Among Men Who Have Sex With Men: A Modeling Study.

Authors:  William C Goedel; Maximilian R F King; Mark N Lurie; Amy S Nunn; Philip A Chan; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.771

View more
  2 in total

1.  Emulating Target Trials to Improve Causal Inference From Agent-Based Models.

Authors:  Eleanor J Murray; Brandon D L Marshall; Ashley L Buchanan
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

2.  Complex systems models for causal inference in social epidemiology.

Authors:  Hiba N Kouser; Ruby Barnard-Mayers; Eleanor Murray
Journal:  J Epidemiol Community Health       Date:  2020-11-10       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.